Vaccine
Australian study sees 70% HPV reduction in gay and bisexual men
May 26, 2021Research and Development Australia, HPV, Vaccine
A school-based human papillomavirus (HPV) vaccination study programme, led by Monash University and Alfred Health, found a 70% reduction in …
Takeda: Dengue vaccine successful in long-term trials & set for global distribution
May 25, 2021Manufacturing and Production EMA, Vaccine, dengue
Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …
Australian PM calls for domestic mRNA vaccine production
May 21, 2021Medical Communications Australia, Moderna, Vaccine, mrna
Australian Prime Minister, Scott Morrison, has invited proposals from pharmaceutical firms to establish domestic manufacturing of mRNA vaccines, to strengthen …
Japan approves Moderna & AstraZeneca COVID-19 vaccines
May 21, 2021Medical Communications COVID-19, Japan, Vaccine
A Japanese government panel has approved Moderna and AstraZeneca’s COVID-19 vaccines for use in adults, bringing the total number of …
FDA authorizes use of Pfizer vaccine for children aged 12-15
May 11, 2021Manufacturing and Production COVID-19, FDA, Pfizer, Vaccine
The FDA announced it has expanded the emergency use of the Pfizer-BioNTech vaccine in children aged 12-15 yesterday.It was determined …
Canada first country to authorise Pfizer vaccine in children aged 12-15
May 6, 2021COVID-19, Canada, Pfizer, Vaccine
Canada has become the first country to authorise the use of Pfizer’s COVID-19 vaccine for children aged between 12 and …
UK government to invest £29.3 million on COVID-19 variant testing
May 5, 2021Research and Development COVID-19, UK government, Vaccine, variants
The UK government has announced an investment of £29.3 million, on top of the £19.7 million already pledged, to be …
Moderna to supply up to 500 million COVID-19 vaccines to COVAX
May 4, 2021Manufacturing and Production, Sales and Marketing COVAX, COVID-19, Moderna, Vaccine, WHO
Moderna have announced a supply agreement with Gavi, the Vaccine Alliance, for up to 500 million doses of their COVID-19 …
Moderna up investments to produce 3 billion COVID vaccine doses in 2022
April 29, 2021COVID-19, Moderna, Vaccine, investment
Moderna have announced it is making new funding commitments to increase supply at its owned and partnered manufacturing facilities, which …
COVID Symptom Study app reveals most common vaccine side effects
April 28, 2021Research and Development COVID-19, Vaccine, data
An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …
Single dose of COVID vaccine can cut transmissions in half
April 28, 2021Research and Development COVID-19, Public Health England, Vaccine
A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …
Pfizer vaccine: Study finds increased breakthrough rates of South African variant
April 19, 2021Sales and Marketing COVID-19, Pfizer, Vaccine, variant
A study published by Tel Aviv University has found an increased breakthrough rate of the South African variant of COVID-19 …
Sanofi to invest €400 million on Singapore vaccine production site
April 12, 2021Sales and Marketing Sanofi, Vaccine
Sanofi have today announced a €400 million investment to create a unique vaccine production centre in Singapore, in partnership with …
EMA launch investigation into J&J’s COVID-19 vaccine amid US blood clot reports
April 12, 2021Sales and Marketing COVID-19, EMA, J&J, JJ, Vaccine
The EMA is reviewing reports of rare blood clots in four people in the US who received Johnson & Johnson’s …
AstraZeneca halt paediatric trial of COVID-19 vaccine amid blood clot probe
April 7, 2021Research and Development AstraZeneca, COVID-19, Vaccine
AstraZeneca has halted the trial of its COVID-19 vaccine on children aged between 6 and 17, while regulators investigate a …
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
